160
Participants
Start Date
August 21, 2024
Primary Completion Date
November 5, 2025
Study Completion Date
November 19, 2027
riliprubart
Pharmaceutical form: Solution Route of administration: IV solution
Placebo
Pharmaceutical form: Solution Route of administration: IV solution
riliprubart
Pharmaceutical form: Solution Route of administration: SC solution
Placebo
Pharmaceutical form: Solution Route of administration: SC solution
IVIg
Pharmaceutical form: Concentrate for solution for infusion (or any other formulation approved locally) Route of administration: IV solution
Placebo
Pharmaceutical form: Placebo to match intravenous immunoglobulin IVIg for IV infusio Route of administration: IV solution
RECRUITING
Investigational Site Number : 1580001, Taipei
RECRUITING
Investigational Site Number : 1580002, Taipei
RECRUITING
Investigational Site Number : 1580003, Kaohsiung City
RECRUITING
Investigational Site Number : 3480003, Budapest
RECRUITING
Investigational Site Number : 0320003, Buenos Aires
RECRUITING
Investigational Site Number : 2080001, Copenhagen
RECRUITING
Investigational Site Number : 0560001, Leuven
RECRUITING
Investigational Site Number : 7560003, Bern
RECRUITING
Investigational Site Number : 3480001, Szeged
RECRUITING
Investigational Site Number : 2080002, Aarhus N
RECRUITING
Investigational Site Number : 0560002, Ghent
RECRUITING
Investigational Site Number : 3480004, Győr
RECRUITING
Columbia University- Site Number : 8400003, New York
RECRUITING
Investigational Site Number : 2030001, Prague
RECRUITING
Dent Neurologic Institute- Site Number : 8400039, Amherst
RECRUITING
Investigational Site Number : 7920004, Bursa
RECRUITING
University of Virginia- Site Number : 8400023, Charlottesville
RECRUITING
Investigational Site Number : 7240008, Majadahonda
RECRUITING
Investigational Site Number : 7240007, Málaga
RECRUITING
Investigational Site Number : 2760005, Hanover
RECRUITING
Investigational Site Number : 4840002, Chihuahua City
RECRUITING
Investigational Site Number : 7240002, Pamplona
RECRUITING
Investigational Site Number : 7240003, Oviedo
RECRUITING
Investigational Site Number : 7920001, Istanbul
RECRUITING
Investigational Site Number : 7920002, Istanbul
RECRUITING
Alabama Neurology Associates- Site Number : 8400019, Homewood
RECRUITING
Investigational Site Number : 7920003, Konya
RECRUITING
University of Cincinnati - Internal Medicine- Site Number : 8400020, Cincinnati
RECRUITING
Investigational Site Number : 7240004, Valencia
RECRUITING
Investigational Site Number : 2760001, Münster
RECRUITING
~Henry Ford Hospital- Site Number : 8400025, Detroit
RECRUITING
Michigan State University- Site Number : 8400038, East Lansing
RECRUITING
Investigational Site Number : 2030003, Hradec Králové
RECRUITING
Investigational Site Number : 2030002, Pardubice
RECRUITING
Investigational Site Number : 4840001, Tlalnepantla
RECRUITING
Investigational Site Number : 2030004, Brno
RECRUITING
Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037, St Louis
RECRUITING
University of Kansas Medical Center- Site Number : 8400010, Kansas City
RECRUITING
Ochsner Clinic Foundation- Site Number : 8400030, New Orleans
RECRUITING
Investigational Site Number : 2030005, Ostrava - Poruba
RECRUITING
Austin Neuromuscular Center, National Neuromuscular Research Institute - Site Number : 8400040, Austin
RECRUITING
Phoenix Neurological Associates - Phoenix- Site Number : 8400014, Phoenix
RECRUITING
USC- Site Number : 8400002, Los Angeles
RECRUITING
~Mass General Hospital- Site Number : 8400009, Boston
RECRUITING
University of California Irvine Medical Center- Site Number : 8400007, Orange
RECRUITING
Investigational Site Number : 2500001, Le Kremlin-Bicêtre
RECRUITING
Investigational Site Number : 1560013, Beijing
RECRUITING
Investigational Site Number : 1560010, Beijing
RECRUITING
Investigational Site Number : 1560005, Beijing
RECRUITING
Investigational Site Number : 1560001, Shanghai
RECRUITING
Investigational Site Number : 1560008, Jinan
RECRUITING
Investigational Site Number : 1560014, Hangzhou
RECRUITING
Investigational Site Number : 1560015, Nanchang
RECRUITING
Investigational Site Number : 1560002, Fuzhou
RECRUITING
Investigational Site Number : 1560009, Changsha
RECRUITING
Investigational Site Number : 1560003, Wuhan
RECRUITING
Investigational Site Number : 1560006, Wuhan
RECRUITING
Investigational Site Number : 1560007, Guangzhou
RECRUITING
Investigational Site Number : 1560012, Guangzhou
RECRUITING
Investigational Site Number : 1560011, Chengdu
RECRUITING
Investigational Site Number : 1560004, Xi'an
RECRUITING
Investigational Site Number : 3760001, Haifa
RECRUITING
Yale University School of Medicine- Site Number : 8400018, New Haven
RECRUITING
AdventHealth Site Number : 8400006, Orlando
RECRUITING
AdventHealth- Site Number : 8400006, Orlando
RECRUITING
Investigational Site Number : 0320001, CABA
RECRUITING
Investigational Site Number : 0320002, Ciudad Autonoma Buenos Aires
RECRUITING
L2IP Instituto de Pesquisas Clinicas- Site Number : 0760006, Brasília
RECRUITING
Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760007, Curitiba
RECRUITING
Instituto do Cerebro - InsCer- Site Number : 0760002, Porto Alegre
RECRUITING
PSEG Centro de Pesquisa Clinica- Site Number : 0760009, São Paulo
RECRUITING
Investigational Site Number : 1240003, London
RECRUITING
Investigational Site Number : 1240006, Montreal
RECRUITING
Investigational Site Number : 1240001, Québec
RECRUITING
Investigational Site Number : 2500005, Nice
RECRUITING
Investigational Site Number : 3920007, Amagasaki
RECRUITING
Investigational Site Number : 3920015, Yokohama
RECRUITING
Investigational Site Number : 3920009, Saga
RECRUITING
Investigational Site Number : 3920012, Higashimatsuyama-shi
RECRUITING
Investigational Site Number : 3920005, Kawagoe
RECRUITING
Investigational Site Number : 3920014, Yaizu
RECRUITING
Investigational Site Number : 3920008, Kodaira-shi
RECRUITING
Investigational Site Number : 3920010, Ōta-ku
RECRUITING
Investigational Site Number : 3920001, Chiba
RECRUITING
Investigational Site Number : 6200003, Braga
RECRUITING
Investigational Site Number : 6200005, Coimbra
RECRUITING
Investigational Site Number : 6200002, Lisbon
RECRUITING
Investigational Site Number : 6200001, Lisbon
RECRUITING
Investigational Site Number : 7240006, Sabadell
RECRUITING
Investigational Site Number : 7520001, Stockholm
RECRUITING
Investigational Site Number : 8260001, Oxford
RECRUITING
Investigational Site Number : 8260003, Inverness
Lead Sponsor
Sanofi
INDUSTRY